Contract analysis

I. EXECUTIVE SUMMARY Calderwood & Harkness LLP ("C&H" or the "Firm") was retained by Meridian Consumer Brands LLC ("Meridian" or "MCB") on September 8, 2025 to prosecute a false-advertising and unfair-competition action against Apex Naturals Inc. ("Apex" or "ANI"). This memorandum sets forth the Firm's recommended litigation strategy, including forum selection, causes of action, preliminary injunction strategy, damag

II. BACKGROUND AND KEY FACTS A. The Parties Meridian Consumer Brands LLC (Plaintiff) Meridian Consumer Brands LLC is a Delaware limited liability company with its principal place of business at 410 West 34th Street, 18th Floor, New York, New York 10001. Meridian is registered to do business in the State of New York and maintains its registered agent at Capitol Filing Services Inc., 28 Liberty Street, Suite 4400, New

1. Clinical Superiority Claim The first and most prominent false claim is a comparative efficacy claim asserting that PuraClear is clinically superior to DermaTrūe. Specifically, the campaign states: "In a controlled clinical study, PuraClear reduced visible acne blemishes 47% faster than the leading DermaTrūe treatment." This claim is presented in both the television and digital video advertisements, typically accom

2. Misleading Price Comparison The second false claim concerns a price comparison designed to create the impression that PuraClear offers comparable or superior acne treatment at a fraction of DermaTrūe's price. The campaign states: "PuraClear delivers premium results at half the price — just $12.99 vs. $28.99 for a comparable DermaTrūe kit." This claim is featured prominently in the television advertisements, in the

3. False "Clean" Ingredients Claim The third false claim asserts that PuraClear is superior to DermaTrūe because it is free of certain ingredients that DermaTrūe purportedly contains. The campaign states: "Unlike DermaTrūe, PuraClear is 100% free of parabens, sulfates, and synthetic fragrances." This claim is featured across the television, digital, and in-store components of the campaign. It is designed to capitaliz

III. FORUM SELECTION A. Recommended Forum: U.S. District Court for the Southern District of New York We recommend filing the Verified Complaint and Motion for Preliminary Injunction in the United States District Court for the Southern District of New York. This forum provides the strongest combination of favorable substantive law, procedural advantages, and practical convenience for the prosecution of this action. Su

IV. CAUSES OF ACTION The Verified Complaint will assert five causes of action. The first — false advertising under the Lanham Act — is the principal federal claim and provides the broadest array of remedies. The four supplemental state-law claims provide additional theories of liability and damages that strengthen the overall case. A. Count I: False Advertising Under the Lanham Act § 43(a), 15 U.S.C. § 1125(a)

Section 43(a) of the Lanham Act creates a federal cause of action against any person who, in commercial advertising or promotion, makes false or misleading representations of fact that are likely to cause damage to a competitor. The elements of a Lanham Act false-advertising claim are well-established: (1) The defendant made a false or misleading statement of fact in commercial advertising or promotion; (2) The state

Section 349 of the New York General Business Law prohibits deceptive acts or practices in the conduct of any business, trade, or commerce. The elements are: (1) The challenged conduct is consumer-oriented; (2) The conduct is misleading in a material way; and (3) The plaintiff suffered injury as a result. The "PuraClear Truth" campaign is plainly consumer-oriented, as it consists of national advertising directed at re

Section 349 provides for statutory damages of $50 per violation (up to $1,000 for knowing or willful violations) as well as recovery of actual damages, treble damages for willful or knowing violations (up to $10,000), and attorneys' fees. While the statutory damages under § 349 are modest in comparison to the Lanham Act remedies, the availability of attorneys' fees and the independent consumer-protection basis for th

Section 350 of the New York General Business Law specifically targets false advertising, prohibiting advertising that is misleading in a material respect. The elements of a § 350 claim substantially overlap with those of § 349, but the statute focuses specifically on advertising conduct rather than the broader category of deceptive acts and practices. The evidentiary basis for the § 350 claim is identical to that for

V. PRELIMINARY INJUNCTION STRATEGY A. Legal Standard A preliminary injunction is an extraordinary remedy available to preserve the status quo and prevent irreparable harm during the pendency of litigation. In the Second Circuit, the standard for obtaining a preliminary injunction requires the movant to demonstrate: (1) A likelihood of success on the merits; (2) A likelihood of irreparable harm in the absence of preli

VI. DAMAGES THEORIES A. Compensatory Damages — Lost Profits Meridian's primary damages theory is compensatory damages measured by lost profits attributable to Apex's false advertising campaign. The lost-profits analysis begins with the observed revenue decline and applies the established gross-margin methodology. DermaTrūe Q3 2025 revenue was $29.4 million, a decline of $7.4 million (20.1%) from the $36.8 million rep

VII. EXPERT WITNESS LINEUP The following experts have been retained or are in the process of being retained to support Meridian's case. Each expert brings specialized expertise essential to establishing key elements of the claims and damages. A. Dr. Eleanor Fisk — Consumer-Perception Survey Expert Affiliation: Fisk Analytics Group LLC, 101 Federal Street, Suite 2600, Boston, MA 02110 Engagement Rate: $850/hr Specialt